Physician

Patrick M. Reagan, M.D.

According to 2025 Medicare claims, Patrick Reagan, M.D. (NPI: 1467686659) practices hematopoietic cell transplantation and cellular therapy in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is UNIVERSITY OF ROCHESTER (NPI: 1821152588; TIN: 160743209) and primary practice location at 14642-0001. Reagan is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Reagan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 122 traditional Medicare patients, billed 554 HCPCS/CPT codes, and received $37,187 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 295 prescription claims across 57 beneficiaries totaling $977,173 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 54 records totaling $1,441,516. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,692 to $37,187. Similarly, Part D prescription costs have moved sharply higher in recent years, from $178,803 to $977,173. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	50	203	$15,692
2016	75	347	$24,356
2017	101	425	$30,489
2018	111	440	$32,147
2019	125	368	$25,568
2020	113	389	$29,032
2021	141	450	$37,269
2022	133	401	$32,917
2023	143	469	$39,342
2024	122	554	$37,187

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	36	142	$178,803
2016	39	366	$315,160
2017	40	239	$370,759
2018	53	292	$560,482
2019	45	191	$344,924
2020	43	210	$273,250
2021	54	360	$333,312
2022	48	225	$354,128
2023	59	282	$769,644
2024	57	295	$977,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	48	99	$107
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	39	175	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	33	47	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	32	36	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	73	144	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	34	1,020	$436,439
Imbruvica	Ibrutinib	18	518	$303,982
Calquence	Acalabrutinib Maleate	16	480	$157,476
Acyclovir	Acyclovir	39	1,165	$490
Prochlorperazine Maleate	Prochlorperazine Maleate	23	180	$279

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$84	Astellas Pharma Global Development
Research Payments	Reported research-related payment or transfer-of-value amount.	52	$1,441,432	Strong Memorial Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick M. Reagan, M.D.?

Tedicare shows public-source Medicare data for Patrick M. Reagan, M.D. (NPI 1467686659), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick M. Reagan, M.D. have ACO affiliation data?

Patrick M. Reagan, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Patrick M. Reagan, M.D.?

Patrick M. Reagan, M.D. is linked to UNIVERSITY OF ROCHESTER (billing NPI 1821152588) in the available physician profile data.

Does Patrick M. Reagan, M.D. have Open Payments data?

Patrick M. Reagan, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.